These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26280937)

  • 1. An update on RNA-targeting therapies for neuromuscular disorders.
    Jirka S; Aartsma-Rus A
    Curr Opin Neurol; 2015 Oct; 28(5):515-21. PubMed ID: 26280937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.
    Sardone V; Zhou H; Muntoni F; Ferlini A; Falzarano MS
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28379182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in exon skipping and splice modulation therapies for neuromuscular diseases.
    Touznik A; Lee JJ; Yokota T
    Expert Opin Biol Ther; 2014 Jun; 14(6):809-19. PubMed ID: 24620745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in therapeutic antisense applications for neuromuscular disorders.
    Aartsma-Rus A; van Ommen GJ
    Eur J Hum Genet; 2010 Feb; 18(2):146-53. PubMed ID: 19809477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Innovative therapeutic approaches for hereditary neuromuscular diseases].
    Kirschner J; Schoser B
    Nervenarzt; 2018 Oct; 89(10):1115-1122. PubMed ID: 30171303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene and splicing therapies for neuromuscular diseases.
    Benchaouir R; Robin V; Goyenvalle A
    Front Biosci (Landmark Ed); 2015 Jun; 20(8):1190-233. PubMed ID: 25961553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for Duchenne muscular dystrophy.
    Verhaart IE; Aartsma-Rus A
    Curr Opin Neurol; 2012 Oct; 25(5):588-96. PubMed ID: 22892952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Gene-Targeting Therapies for Motor Neuron Diseases and Muscular Dystrophies.
    Chamakioti M; Karantzelis N; Taraviras S
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting RNA to treat neuromuscular disease.
    Muntoni F; Wood MJ
    Nat Rev Drug Discov; 2011 Aug; 10(8):621-37. PubMed ID: 21804598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pharmacotherapies for genetic neuromuscular disorders: opportunities and challenges.
    Ricci F; Vacchetti M; Brusa C; Vercelli L; Davico C; Vitiello B; Mongini T
    Expert Rev Clin Pharmacol; 2019 Aug; 12(8):757-770. PubMed ID: 31220956
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic therapies for inherited neuromuscular disorders.
    Scoto M; Finkel R; Mercuri E; Muntoni F
    Lancet Child Adolesc Health; 2018 Aug; 2(8):600-609. PubMed ID: 30119719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-based therapies of neuromuscular disorders: an update and the pivotal role of patient organizations in their discovery and implementation.
    Braun S
    J Gene Med; 2013; 15(11-12):397-413. PubMed ID: 24123726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making sense of antisense oligonucleotides: A narrative review.
    Goyal N; Narayanaswami P
    Muscle Nerve; 2018 Mar; 57(3):356-370. PubMed ID: 29105153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-targeting approaches for neuromuscular diseases.
    Le Roy F; Charton K; Lorson CL; Richard I
    Trends Mol Med; 2009 Dec; 15(12):580-91. PubMed ID: 19906562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities and challenges for the development of antisense treatment in neuromuscular disorders.
    van Putten M; Aartsma-Rus A
    Expert Opin Biol Ther; 2011 Aug; 11(8):1025-37. PubMed ID: 21510827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seeking a better landscape for therapy development in neuromuscular disorders.
    Larkindale J; Porter JD
    Muscle Nerve; 2018 Jan; 57(1):16-19. PubMed ID: 28881009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapeutic strategies and relevant clinical trials in neuromuscular disorder in China.
    Hu C; Li X
    Gene Ther; 2020 Aug; 27(7-8):321-328. PubMed ID: 32591735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gene-specific treatment approaches in muscle diseases].
    Lehmann Urban D; Schneider I
    Nervenarzt; 2020 Apr; 91(4):318-323. PubMed ID: 32076754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy for neuromuscular disorders.
    Arnett AL; Chamberlain JR; Chamberlain JS
    Curr Opin Genet Dev; 2009 Jun; 19(3):290-7. PubMed ID: 19411172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in therapeutic RNA-targeting.
    van Ommen GJ; Aartsma-Rus A
    N Biotechnol; 2013 Mar; 30(3):299-301. PubMed ID: 23369867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.